hCAII-IN-9

hCAII-IN-9

Catalog No. M36504

hCAII-IN-9 is a potent carbonic anhydrase inhibitor with IC50 values of 1.18 μM for hCA II, 0.17 μM for hCA IX, and 2.99 μM for hCA XII. It is not blood-brain barrier permeable.

Size Price / USD Stock Quantity
2MG 103 Get Quote
5MG 141 Get Quote
10MG 204 Get Quote
25MG 334 Get Quote
50MG 507 Get Quote
100MG 714 Get Quote
500MG 1467 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    hCAII-IN-9
  • Brief Description
  • Description
  • Storage
  • Note
    Research use only, not for human use.
  • Reference
    1. Hussain Z, et al. Synthesis and Evaluation of Amide and Thiourea Derivatives as Carbonic Anhydrase (CA) Inhibitors. ACS Omega. 2022 Dec 6;7(50):47251-47264. ?
molnova catalog
related products
  • Histone acetyltransf...

    Histone acetyltransferase p300 Inhibitor 4c is a 2-aminothiazole derivative. Histone acetyltransferase p300 Inhibitor 4c inhibited hCA I, hCA II, AChE and BChE with Ki values of 0.008 ± 0.001, 0.124 ± 0.017, 0.129 ± 0.030 and 0.083 ± 0.041 μM. 0.017, 0.129 ± 0.030 and 0.083 ± 0.041 μM.

  • Acetazolamide sodium

    Acetazolamide sodium (OT-302 sodium) is a potent carbonic anhydrase (CA)IX inhibitor with diuretic, antigonococcal, and antihypertensive activity and may be used for indications such as epilepsy, glaucoma, edema, and altitude sickness.

  • CAIX Inhibitor S4

    CAIX Inhibitor S4 is an effective inhibitor of carbonic anhydrase IX/XII with a Ki of 7 nM and 2 nM, respectively. The Kis for CA II and CA I are 546 and 5600 nM.